en

PRODUCT DETAIL

Benlysta 200 mg injekčný roztok naplnený v injekčnom pere

Code 5993C
MA number EU/1/11/700/003
Product Form: sol ira 1x1 ml/200 mg (striek.inj.skl. v napl.pere)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 59 - IMMUNOPRAEPARATA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L04 Immunosuppressants
L04A Immunosuppressants
L04AA Selective immunosuppressants
L04AA26 Belimumab
Shelf life: 36
Route of admin.: Subcutaneous use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 13.07.2011
SmPC + PL: European Medicines Agency's database
Dokument: DHPC Benlysta 3 4 2012.pdf  
Safety feature Yes
Data update: 13.05.2021
eu-flag.png sk-flag.png